Halozyme Therapeutics reported $113.15M in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 88.22M 7.11M
Agios Pharmaceuticals AGIO:US $ 57.9M 2.75M
Alnylam Pharmaceuticals ALNY:US $ 610.66M 56.01M
Amarin AMRN:US $ 364.74M 5.69M
Amgen AMGN:US $ 14842M 257M
Aptinyx Inc APTX:US $ 6.28M 2.9M
Arena Pharmaceuticals ARNA:US $ 53.36M 11.48M
Baxter International BAX:US $ 3441M 97M
Cara Therapeutics CARA:US $ 15.53M 358K
Cytokinetics CYTK:US $ 80.87M 19.1M
Eli Lilly And LLY:US $ 13682M 1411.2M
Esperion Therapeutics ESPR:US $ 78.48M 4.16M
Halozyme Therapeutics HALO:US $ 113.15M 1.1M
Immunogen IMGN:US $ 111.78M 8.53M
Intra Cellular Therapies ITCI:US $ 49.9M 0.53M
Intrexon XON:US $ 28.99M 0.12M
JAZZ PHA JAZZ:US $ 735.05M 145.54M
Mannkind MNKD:US $ 50.03M 10.4M
Minerva Neurosciences NERV:US $ 3.08M 1.36M
Nektar Therapeutics NKTR:US $ 139.97M 8.95M
Peregrine Pharmaceuticals PPHM:US $ 63.25M 7.69M
Rigel Pharmaceuticals RIGL:US $ 59.28M 0.26M
United Therapeutics UTHR:US $ 320M 8.6M
Vanda Pharmaceuticals VNDA:US $ 72M 0.01M